Meril Cardiovascular has developed new concepts in engineering employing novel designs, drug delivery technologies (for stents & balloons) and affordable catheter-based systems that effectively bridge the gap between countries with ailing populations and struggling health care needs.
Today a portfolio of cleverly iterated devices ranging from low injury coronary stents; a Bioresorbable Scaffold; a morphology-modifying balloon catheter, a tissue covered stent graft and a Transcatheter Aortic Valves Replacement system (TAVI) are either successfully commercialized or are under development.
Backed by a team of Global Scientific advisors, all our products are produced in our state-of-the-art facility at Vapi, Gujarat. This facility, spread over a sprawling 40,000 sq.ft is established on the rock solid CGMP guidelines and adheres to the ISO13485: 2003 quality standards.
Unique and completely integrated manufacturing system ensures backward integration, flawless man-material movement, complete control over processes with strong validation to eliminate any production errors. All processes are conducted in-house for manufacturing along with sterilization, analytical and microbiological QA/QC tests.
Meril is committed to lead innovation in cardiac treatment and care and has allocated additional resources to facilitate research that will empower individuals with better health.
At Meril, we ask precise question that makes phenomenal difference.